The Future of Immunotherapy, CAR-T and Beyond


Shannon L. Maude,
Assistant Professor of Pediatrics, Divison of Oncology
Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine

Dr. Shannon Maude is an oncologist in the Cancer Immunotherapy Program at Children’s Hospital of Philadelphia and an Assistant Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine. After earning her undergraduate degree in biology from the University of Virginia, Dr. Maude received her MD and PhD from the University of Pennsylvania School of Medicine, and completed her residency in pediatrics as well as a fellowship in pediatric hematology-oncology at Children’s Hospital of Philadelphia. Dr. Maude is Fellowship Director of the Cancer Immunotherapy and BMT Fellowship at Children’s Hospital of Philadelphia and a Medical Director in the Center for Cellular Immunotherapies at the University of Pennsylvania. She leads clinical trials of engineered T cell therapies for childhood cancers. Dr. Maude has a special interest in novel therapies for acute lymphoblastic leukemia, particularly targeted therapy approaches and engineered T cell therapy.

Comments are closed.